Silvio Scalzo
Papers
4
Total Citations
92
H-Index
3
About
Dr. Silvio Scalzo is a pioneering urologic surgeon whose research sits at the intersection of surgical innovation, patient outcomes, and planetary health. His primary focus is on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH) and prostate cancer, with a particular emphasis on optimizing functional recovery. In a landmark 2021 prospective randomized study (55 citations), Dr. Scalzo definitively compared Holmium laser enucleation (HoLEP) against robotic simple prostatectomy for large-volume prostates (≥120 mL), providing crucial evidence for surgical decision-making in complex cases. Demonstrating remarkable breadth, he also led a groundbreaking 2023 multicenter study that quantified the carbon footprint of laparoscopic versus robotic radical prostatectomy, a novel contribution linking surgical practice to global climate change. His recent 2024 work uses preoperative MRI to correlate preserved urethral length with early continence recovery after robotic prostatectomy, directly addressing the critical patient concern of post-surgical incontinence. Through these high-impact studies, Dr. Scalzo is not only refining surgical techniques but also pioneering the integration of environmental sustainability into urologic care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4